Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Review Article
Urine Formaldehyde: A Non-Invasive Marker for Alzheimer's Disease?
Zhiqian Tong*Alzheimer’s Disease Center, Beijing Institute for Brain Disorders, Capital Medical University, Beijing 100069, China
- Corresponding Author:
- Zhiqian Tong
Alzheimer’s Disease Center
Beijing Institute for Brain Disorders
Capital Medical University, Beijing 100069, China
Tel: +861083911987
E-mail: tzqbeida@ccmu.edu.cn
Received date: June 26, 2017; Accepted date: June 28, 2017; Published date: July 05, 2017
Citation: Tong Z (2017) Urine Formaldehyde: A Non-Invasive Marker for Alzheimer’s Disease? J Alzheimers Dis Parkinsonism 7:345. doi:10.4172/2161- 0460.1000345
Copyright: © 2017 Tong Z. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Given the dramatic increase in Alzheimer’s disease (AD) cases globally, the identification of a suitable biomarker in easily collectable samples (e.g. plasma, blood, saliva and urine) for diagnosing AD is therefore of utmost importance. Previous studies indicated that excess formaldehyde contributes to Aβ aggregation and Tau hyper phosphorylation, both phenomena directly linked to the progress of AD. Our 7 year’s cross-sectional survey showed that morning urine formaldehyde levels were correlated positively with the severe degree of sporadic dementia, suggesting that urine formaldehyde measurement most likely acts as a suitable non-invasive method to support diagnostic purposes. In this a short review article, we provide a short overview of the animal and clinical studies on the possible mechanisms of exogenous and endogenous factors cause formaldehyde accumulation, which plays a critical role in the pathogenesis of both genetic dementia and sporadic dementia. Urine formaldehyde will be of significant value for the non-invasive diagnosis of cognitive ability in AD, but the more sensitive method for detecting formaldehyde concentrations and a longitudinal (long-term follow-up) study would be required to prove conclusively such a relationship between urine formaldehyde and dementia.
